Frederic B. Thalheimer

2.1k total citations
24 papers, 744 citations indexed

About

Frederic B. Thalheimer is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Frederic B. Thalheimer has authored 24 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 12 papers in Genetics. Recurrent topics in Frederic B. Thalheimer's work include Virus-based gene therapy research (12 papers), CAR-T cell therapy research (12 papers) and Immune Cell Function and Interaction (8 papers). Frederic B. Thalheimer is often cited by papers focused on Virus-based gene therapy research (12 papers), CAR-T cell therapy research (12 papers) and Immune Cell Function and Interaction (8 papers). Frederic B. Thalheimer collaborates with scholars based in Germany, United States and Switzerland. Frederic B. Thalheimer's co-authors include Christian J. Buchholz, Shiwani Agarwal, Michael A. Rieger, Timm Schroeder, Sylvia Hartmann, Jessica Hartmann, Nadine Haetscher, Susanne Wingert, R. Bender and Els Verhoeyen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Biomaterials.

In The Last Decade

Frederic B. Thalheimer

22 papers receiving 741 citations

Peers

Frederic B. Thalheimer

ONCOL

GENET

IMMUN

Semjon Willier Germany

Chenggong Li China

Yinmeng Yang United States

Greta Maria Paola Giordano Attianese Switzerland

Sanfang Tu China

Stefanie Lesch Germany

Tatsunori Goto Japan

Imran G. House Australia

Jessica Hartmann Germany

Caroline Arber United States

Semjon Willier Germany

Frederic B. Thalheimer

422 ×0.9

ONCOL

343 ×0.9

131 ×0.5

GENET

175 ×0.9

IMMUN

94 ×0.6

Citations per year, relative to Frederic B. Thalheimer Frederic B. Thalheimer (= 1×) peers Semjon Willier

Countries citing papers authored by Frederic B. Thalheimer

Since Specialization

Citations

This map shows the geographic impact of Frederic B. Thalheimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederic B. Thalheimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederic B. Thalheimer more than expected).

Fields of papers citing papers by Frederic B. Thalheimer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederic B. Thalheimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederic B. Thalheimer. The network helps show where Frederic B. Thalheimer may publish in the future.

Co-authorship network of co-authors of Frederic B. Thalheimer

This figure shows the co-authorship network connecting the top 25 collaborators of Frederic B. Thalheimer. A scholar is included among the top collaborators of Frederic B. Thalheimer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederic B. Thalheimer. Frederic B. Thalheimer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hein, Sascha, et al.. (2025). ApoE2-DARPin fusion proteins enable selective RNA transfer to CD8 T cells by lipid nanoparticles. Journal of Controlled Release. 388(Pt 2). 114377–114377.

Thalheimer, Frederic B., et al.. (2025). Enhanced conversion of T cells into CAR T cells by modulation of the MAPK/ERK pathway. Cell Reports Medicine. 6(2). 101970–101970. 2 indexed citations

Thalheimer, Frederic B., et al.. (2024). Early induction of cytokine release syndrome by rapidly generated CAR T cells in preclinical models. EMBO Molecular Medicine. 16(4). 784–804. 4 indexed citations

Grimm, Dirk, et al.. (2024). T-cell specific in vivo gene delivery with DART-AAVs targeted to CD8. Molecular Therapy. 32(10). 3470–3484. 8 indexed citations

Herrera-Carrillo, Elena, Frederic B. Thalheimer, Kathleen Börner, et al.. (2023). AAV vectors displaying bispecific DARPins enable dual-control targeted gene delivery. Biomaterials. 303. 122399–122399. 14 indexed citations

Kovacs, Richard J., et al.. (2023). Substantially improved gene transfer to interneurons with second-generation glutamate receptor-targeted DART-AAV vectors. Journal of Neuroscience Methods. 399. 109981–109981. 3 indexed citations

Thalheimer, Frederic B., et al.. (2023). CAR Gene Delivery by T‐cell Targeted Lentiviral Vectors is Enhanced by Rapamycin Induced Reduction of Antiviral Mechanisms. Advanced Science. 10(35). e2302992–e2302992. 11 indexed citations

Agarwal, Shiwani, et al.. (2022). In vivo generation of CAR T cells in the presence of human myeloid cells. Molecular Therapy — Methods & Clinical Development. 26. 144–156. 19 indexed citations

Thalheimer, Frederic B., et al.. (2021). Monitoring CAR T cell generation with a CD8-targeted lentiviral vector by single-cell transcriptomics. Molecular Therapy — Methods & Clinical Development. 23. 359–369. 11 indexed citations

10.

Agarwal, Shiwani, et al.. (2020). In Vivo Generation of CAR T Cells Selectively in Human CD4+ Lymphocytes. Molecular Therapy. 28(8). 1783–1794. 121 indexed citations

11.

Hadjati, Jamshid, Zahra Madjd, Hamid Reza Mirzaei, et al.. (2020). Highly Efficient Generation of Transgenically Augmented CAR NK Cells Overexpressing CXCR4. Frontiers in Immunology. 11. 2028–2028. 55 indexed citations

12.

Frisch, Janina, Christine E. Engeland, Frederic B. Thalheimer, et al.. (2019). Tumor-Specific Delivery of Immune Checkpoint Inhibitors by Engineered AAV Vectors. Frontiers in Oncology. 9. 52–52. 40 indexed citations

13.

Hartmann, Jessica, Frederic B. Thalheimer, Konstantin Khodosevich, et al.. (2019). GluA4-Targeted AAV Vectors Deliver Genes Selectively to Interneurons while Relying on the AAV Receptor for Entry. Molecular Therapy — Methods & Clinical Development. 14. 252–260. 18 indexed citations

14.

Thalheimer, Frederic B., Sylvia Hartmann, R. Bender, et al.. (2018). In vivo generation of human CD 19‐ CAR T cells results in B‐cell depletion and signs of cytokine release syndrome. EMBO Molecular Medicine. 10(11). 142 indexed citations

15.

Wingert, Susanne, et al.. (2016). DNA-damage response gene GADD45A induces differentiation in hematopoietic stem cells without inhibiting cell cycle or survival. Stem Cells. 34(3). 699–710. 46 indexed citations

16.

Haetscher, Nadine, Yonatan Feuermann, Susanne Wingert, et al.. (2015). STAT5-regulated microRNA-193b controls haematopoietic stem and progenitor cell expansion by modulating cytokine receptor signalling. Nature Communications. 6(1). 8928–8928. 41 indexed citations

17.

Thalheimer, Frederic B., Katharina Gerlach, Stefanie Böhm, et al.. (2015). Single-Stranded DNA-Binding Transcriptional Regulator FUBP1 Is Essential for Fetal and Adult Hematopoietic Stem Cell Self-Renewal. Cell Reports. 11(12). 1847–1855. 30 indexed citations

18.

Haetscher, Nadine, Yonatan Feuermann, Susanne Wingert, et al.. (2015). STAT5-regulated microrna-193B controls hematopoietic stem cell expansion and leukemogenesis by modulating cytokine receptor signaling. Experimental Hematology. 43(9). S91–S91. 1 indexed citations

19.

Thalheimer, Frederic B., Susanne Wingert, Nadine Haetscher, et al.. (2014). Cytokine-regulated GADD45G induces differentiation and lineage selection in hematopoietic stem cells. Experimental Hematology. 42(8). S57–S57.

20.

Thalheimer, Frederic B., Susanne Wingert, Nadine Haetscher, et al.. (2014). Cytokine-Regulated GADD45G Induces Differentiation and Lineage Selection in Hematopoietic Stem Cells. Stem Cell Reports. 3(1). 34–43. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact